MarketsStocksWINDLAS
WI

Windlas Biotech Ltd

NSE: WINDLASBSE: 543329Healthcare
Download Research Report7-page PDF
801.10
-1.60%
NSE · auto-updates while market open
Prev Close
₹914.60
Day High
₹828.00
Day Low
₹799.20
Mkt Cap
₹1,723 Cr
P / E
25.9
P / B
3.0
ROE
12.2%
52W High
₹1,097.90
52W Low
₹697.40
Key Metrics
Market Cap
₹1,723 Cr
P / E
25.93
P / B
2.96
EV / EBITDA
16.67
ROCE
16.1%
ROE
12.2%
Debt / Equity
0.05
Book Value
₹275.20
EPS
₹31.60
Div Yield
0.7%
Face Value
₹5
Promoter Holding
63.3%
Revenue · ₹ Cr
466
FY22
513
FY23
631
FY24
760
FY25
904
FY26
Net Profit · ₹ Cr
38
FY22
43
FY23
58
FY24
61
FY25
66
FY26
EPS · ₹ per share
₹18.8
FY22
₹19.7
FY23
₹28.0
FY24
₹29.2
FY25
₹31.6
FY26
P / E Ratio · price ÷ TTM EPS
819304237170-3Mar 22Aug 23Jan 25Jun 26
P/E 25.8×Median 21.2×TTM EPS
Q1 2026 snapshot
Sales
₹243 Cr
Operating profit
-
OPM
-
Net profit
₹16 Cr
EPS
₹7.58
Scorecard · 7 axes
Quality
Strong
75/100
Valuation
Avg
25.9×
Growth
Good
+16.5%
Profitability
Avg
14.1%
Performance
Bad
-11.5%
Entry Point
Good
73%
Red Flags
Strong
0 flags
Shareholding Pattern
63.3%Promoter
Promoter63.3%
FII1.0%
DII10.2%
Public25.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue195.019207.64215.33226.04237.67242.85
Net Profit15.57616.28117.66417.815.00215.99
NPM %8.0%7.8%8.2%7.9%6.3%6.6%
AlertPre-trade